A branford diagnostics biotech that developed a handheld device to detect organisms that cause infectious diseases is expanding its footprint in the shoreline town with a planned move to a new 16,200squarefoot facility. Biotechcareers is funded in part by the national science foundation. The company is also using chitin as the basis for programs in novel allergy and asthma therapies, vaccine adjuvants, and nutritional products. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. Fimbrion therapeautics pioneers antivirulence solutions to treat utis. Ptc therapeutics reports inducement grants under nasdaq. Axerion therapeutics october 2010 january 2014 3 years 4. While many therapies for ad are in latestage clinical testing, rational drug design based on distinct signaling pathways in this disorder is only now emerging. Human ngr10fc was expressed in a stable chos cell line at axerion therapeutics. View george maynards profile on linkedin, the worlds largest professional community. Stock protein solutions at 10 mgml were stable for greater than 1 year at. Intarcia therapeutics rethinking the future of medicine. The lots will have a staggered closing time with 2 closing every minute in numerical order.
Aspyrian therapeutics is a clinical stage oncology company developing novel precisiontargeted therapies based on the photoimmunotherapy technology pit platform. Axerion of new haven, connecticut, through its eli whitney fund. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. Hyperion therapeutics is a biopharmaceutical company focused on creating treatments for urea cycle disorders and other rare diseases. If you do not receive an email within 10 minutes, your email address may not be registered, and you may need to create a new wiley online library. Gaba and schizophrenia targets and emerging therapies. Jane pritchett henderson has been appointed vp of business development for ista. Siteone therapeutics is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids. Addex therapeutics is a clinicalstage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Clinical practice guidelines for the management of degenerative cervical myelopathy and acute traumatic spinal cord injury.
A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the. We are rethinking the future of medicine with people at the center of the experience. Living with a rare disease isnt just about the treatment, its also about channeling uncertainty and fear into something. New haven, ct, usa i may 1, 2012 i axerion therapeutics, inc. Alrn, the clinicalstage leader in the field of stabilized, cellpermeating peptides, announced today the promotion of richard j.
Intravitreal delivery of human ngrfc decoy protein. He and his team spent a halfdozen years investigating the bodys inability to repair itself following injury to the central nervous system, and developing a drug to block growth inhibitors. The project involves developing a compound nogo receptor decoy to rewire nerve cells that promote the recovery of neurological function. Antivirulence cmannosides as antibioticsparing, oral therapeutics for urinary tract infections. New havenbased biotech company advances innovative treatments for neurological injuries and diseases. In 2010, strittmatter formed a company called axerion therapeutics with the yale office of cooperative research. Pit utilizes antibody conjugates that accumulate at the tumor after systemic infusion and can be activated with light to induce rapid, specific, and robust tumor destruction. This drug is currently developed by cara therapeutics. Branford biotech expanding to bigger space after raising. This months profile group, alzheimers startups face a discovery and clinical crossroads, features profiles of alzprotect, axerion therapeutics, cognition therapeutics and galantos pharma. Alexion is a global biopharmaceutical company focused on developing lifechanging therapies for people living with rare disorders. Axerion of new haven, connecticut, through its eli.
Learn how to convert outlook e mails to pdf with adobe acrobat in windows 1087. Therapeutics definition of therapeutics by the free. Henderson was most recently chief financial officer and executive vp. Axerion was established in new haven to develop and commercialize intellectual property licensed from dr. Cara, a biopharmaceutical company focused on developing.
How to save outlook email as pdf 3 methods available. Facebook view on facebook linkedin view on linkedin contact email kim. He has focused his academic and business career on the application of developmental biology to. After more than doubling, esperion therapeutics, inc.
Development of nogo receptor decoy for the treatment of spinal cord injury, george maynard, phd, axerion therapeutics, inc. The expression vector encodes aa residues 10 of human ngr1 with the cys266ala and cys309ala substitutions fused to the fc domain of human igg1, as described for rat protein previously. Pdf cr845 difelikefalin, a kappa receptors agonist in phase iii. Fimbrion and gsk to develop novel antibacterial therapy for urinary tract infections. Traumatic spinal cord injurys secondary injury cascade the secondary injury cascade is a series of changes that begin within just a few hours after the sci and may continue months past the initial injury. See who you know at axerion therapeutics, leverage your professional network, and get hired. The cover image representing article number 1900161 by jonathan f lovell and co. Aileron therapeutics announces the promotion of richard j. Fyn kinase inhibition as a novel therapy for alzheimers.
Degenerative cervical myelopathy, spinal cord injury. On the day the auction is set to close, each lot will clearly countdown the time left until closing. Based at yale university in new haven, the team found that mice with ab plaques but no prpc showed no cognitive impairment. The regulation and function of lactate dehydrogenase a. Axerion therapeutics is focused on the research and development of therapeutics for neurological diseases and injuries. Contact siteone therapeutics, headquartered in bozeman, montana with a research team in south san francisco, california, is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids. Intarcia therapeutics is dedicated to redesigning the treatment of chronic disease. You are cordially invited to attend the 2018 annual meeting of stockholders of axsome therapeutics, inc. About us celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Alzheimers disease ad is a devastating neurodegenerative disorder, afflicting more than onethird of people over the age of 85. It forms a new principle to treat chronic or postoperative pain by a peripheral acting. Guidelines for the management of degenerative cervical myelopathy and acute spinal cord injury. Translational neuropharmacology consulting, llc, potomac, md, usa.
Renetxs erika smith fights the good fight against spinal. Ct invests in yale alzheimers therapy hartford business. Intravitreal delivery of human ngrfc decoy protein regenerates. Ptct today announced that on october 25, 2019 it approved nonstatutory stock options to purchase an aggregate of 339,875 shares of its common stock to 27 new employees. Ovesco has developed a clipping system that imitates the mechanics the geometry and force pattern of a surgical suture, but with advantages. The current knowledge of the role of ldha in the brain and its potential as a therapeutic target for brain tumors will also be highlighted. The production of human ngr10fc by expression in a stable chos cell line at axerion therapeutics has been described. The work we do is guided by people living with rare and devastating diseases. Human ngrfc decoy protein via lumbar intrathecal bolus. Our pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system andor directly inhibit tumors to treat specific types of cancer or other diseases. Using proprietary assays, cognition therapeutics inc. Abstract axonal growth and neurological recovery after traumatic spinal cord injury sci is limited by the presence of inhibitory proteins in myelin, several of which act via the ngr1 protein in n. Axerion therapeutics is a biotech company focused on developing innovative. Wanstall to chief financial officer and treasurer, effective immediately.
154 250 1267 494 1277 698 1276 143 448 1021 155 139 1071 1487 541 419 1342 765 430 354 525 1479 533 1336 1509 755 57 1505 121 647 673 559 438 436 907 272 816 872 676 223 1310 17 823